ArticleScientific reports2024
SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation.
Kevin Schmidt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it